Intersection of nuclear receptors and the proteasome on the epigenetic landscape

Environmental and Molecular Mutagenesis

Volumn 49, Issue 1, 2008, Pages 83-95

  Kinyamu, H Korimi ^a   Jefferson, Wendy N ^a   Archer, Trevor K ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

DNA methylation; Epigenetics; Histone modifications; Nuclear receptors; Proteasome

Indexed keywords

CELL NUCLEUS RECEPTOR; HISTONE; PROTEASOME;

DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; PROTEIN DEGRADATION; REVIEW;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; MODELS, BIOLOGICAL; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID;

EID: 39749157043     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20360     Document Type: Review

References (127)

1. Allis CD, Jenuwein T, Reinberg D. 2007. Epigenetics. Caparros M-L, editor. Cold Spring Harbor Laboratory Press. New York: Woodbury. p 1-61.
2. Anway MD, Cupp AS, Uzumcu M, Skinner MK. 2005. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308:1466-1469.
3. Aoyagi S, Archer TK. 2007. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription. Mol Endocrinol 21:843-856.
4. Ayyanathan K, Lechner MS, Bell P, Maul GG, Schultz DC, Yamada Y, Tanaka K, Torigoe K, Rauscher FJ III. 2003. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: A mammalian cell culture model of gene variegation. Genes Dev 17:1855-1869.
5. Berger SL. 2007. The complex language of chromatin regulation during transcription. Nature 447:407-412.
6. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ, McMahon S, Karlsson EK, Kulbokas EJ III, Gingeras TR, Schreiber SL, Lander ES. 2005. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120:169-181.
7. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315-326.
8. Bernstein BE, Meissner A, Lander ES. 2007. The mammalian epigenome. Cell 128:669-681.
9. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21.
10. Bird A. 2007. Perceptions of epigenetics. Nature 447:396-398.
11. Bird AP, Wolffe AP. 1999. Methylation-induced repression - Belts, braces, and chromatin. Cell 99:451-454.
12. Chan SW, Hong W. 2001. Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription. J Biol Chem 276:28402-28412.
13. Chen J, Kinyamu HK, Archer TK. 2006. Changes in attitude, changes in latitude: Nuclear receptors remodeling chromatin to regulate transcription. Mol Endocrinol 20:1-13.
14. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, Rappsilber J, Hansen KH, Salcini AE, Helin K. 2007. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128:1063-1076.
15. Ciechanover A. 2006. The ubiquitin proteolytic system: From a vague idea, through basic mechanisms, and onto human diseases and drug targeting. Neurology 66(2 Suppl 1):S7-S19.
16. Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH, Helin K. 2006. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442:307-311.
17. Collins GA, Tansey WP. 2006. The proteasome: A utility tool for transcription? Curr Opin Genet Dev 16:197-202.
18. Couse JF, Curtis Hewitt S, Korach KS. 2000. Receptor null mice reveal contrasting roles for estrogen receptor α and β in reproductive tissues. J Steroid Biochem Mol Biol 74:287-296.
19. Coux O, Tanaka K, Goldberg AL. 1996. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847.
20. Daniel JA, Pray-Grant MG, Grant PA. 2005. Effector proteins for methylated histones: An expanding family. Cell Cycle 4:919-926.
21. Dennis AP, Lonard DM, Nawaz Z, O'Malley BW. 2005. Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II. J Steroid Biochem Mol Biol 94:337-346.
22. Deroo BJ, Rentsch C, Sampath S, Young J, DeFranco DB, Archer TK. 2002. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 22:4113-4123.
23. Di Stefano L, Ji JY, Moon NS, Herr A, Dyson N. 2007. Mutation of Drosophila Lsd1 disrupts H3-K4 methylation, resulting in tissue-specific defects during development. Curr Biol 17:808-812.
24. Dolinoy DC, Huang D, Jirtle RL. 2007. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 104:13056-13061.
25. Dreijerink KM, Mulder KW, Winkler GS, Hoppener JW, Lips CJ, Timmers HT. 2006. Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 66:4929-4935.
26. Esteller M. 2007. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8:286-298.
27. Ezhkova E, Tansey WP. 2004. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Mol Cell 13:435-442.
28. Ferdous A, Gonzalez F, Sun L, Kodadek T, Johnston SA. 2001. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell 7:981-991.
29. Ferdous A, Kodadek T, Johnston SA. 2002. A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry 41:12798-12805.
30. Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, Perez-Burgos L, Opravil S, Mechtler K, Schotta G, Jenuwein T. 2006. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 20:1557-1562.
31. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37:391-400.
32. Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS, Ju BG, Ohgi KA, Wang J, Escoubet-Lozach L, Rose DW, Glass CK, Fu XD, Rosenfeld, MG. 2007. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128:505-518.
33. Gearhart MD, Corcoran CM, Wamstad JA, Bardwell VJ. 2006. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol Cell Biol 26:6880-6889.
34. Gillette TG, Gonzalez F, Delahodde A, Johnston SA, Kodadek T. 2004. Physical and functional association of RNA polymerase II and the proteasome. Proc Natl Acad Sci USA 101:5904-5909.
35. Goldberg AD, Allis CD, Bernstein E. 2007. Epigenetics: A landscape takes shape. Cell 128:635-638.
36. Goll MG, Bestor TH. 2005. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 74:481-514.
37. Gonzalez F, Delahodde A, Kodadek T, Johnston SA. 2002. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296:548-550.
38. Grewal SI, Moazed D. 2003. Heterochromatin and epigenetic control of gene expression. Science 301:798-802.
39. Halliwell B. 2006. Proteasomal dysfunction: A common feature of neurodegenerative diseases? Implications for the environmental origins of neurodegeneration. Antioxid Redox Signal 8:2007-2019.
40. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M, Yagyu R, Nakamura Y. 2004. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 6:731-740.
41. Huang WW, Yin Y, Bi Q, Chiang TC, Garner N, Vuoristo J, McLachlan JA, Ma L. 2005. Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol 19:669-682.
42. Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH. Whetstine JR, Bonni A, Roberts TM, Shi Y. 2007. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128:1077-1088.
43. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293:1074-1080.
44. Jirtle RL, Skinner MK. 2007. Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253-262.
45. Jones PA, Baylin SB. 2007. The epigenomics of cancer. Cell 128:683-692.
46. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191.
47. Kinyamu HK, Archer TK. 2007. Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription. Mol Cell Biol 27:4891-4904.
48. Kinyamu HK, Chen J, Archer TK. 2005. Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 34:281-297.
49. Kishimoto M, Fujiki R, Takezawa S, Sasaki Y, Nakamura T, Yamaoka K, Kitagawa H, Kato S. 2006. Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr J 53:157-172.
50. Klose RJ, Bird AP. 2006. Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 31:89-97.
51. Klose RJ, Zhang Y. 2007. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 8:307-318.
52. Klose RJ, Kallin EM, Zhang Y. 2006. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 7:715-727.
53. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, Gilliland DG, Zhang Y, Kaelin WG Jr. 2007. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128:889-900.
54. Kornberg RD. 1974. Chromatin structure: A repeating unit of histones and DNA. Science 184(139):868-871.
55. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705.
56. Lan F, Zaratiegui M, Villen J, Vaughn MW, Verdel A, Huarte M, Shi Y, Gygi SP, Moazed D, Martienssen RA, Shi Y. 2007. S. pombe LSD1 homologs regulate heterochromatin propagation and euchromatic gene transcription. Mol Cell 26:89-101.
57. Laribee RN, Shibata Y, Mersman DP, Collins SR, Kemmeren P, Roguev A, Weissman JS, Briggs SD, Krogan NJ, Strahl BD. 2007. CCR4/NOT complex associates with the proteasome and regulates histone methylation. Proc Natl Acad Sci USA 104:5836-5841.
58. Larsen P, Kronenberg H, Melmed S, Polonsky K. 2003. Williams Textbook of Endocrinology. 10th edition. Philadelphia, PA: Elsevier, Inc.
59. Lee D, Ezhkova E, Li B, Pattenden SG, Tansey WP, Workman JL. 2005. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell 123:423-436.
60. Lee DY, Northrop JP, Kuo MH, Stallcup MR. 2006. Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. J Biol Chem 281:8476-8485.
61. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
62. Lee MG, Norman J, Shilatifard A, Shiekhattar R. 2007a. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 128:877-887.
63. Lee N, Zhang J, Klose RJ, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y. 2007b. The trithorax-group protein Lid is a histone H3 trimethyl-Lys4 demethylase. Nat Struct Mol Biol 14:341-343.
64. Li B, Carey M, Workman JL. 2007. The role of chromatin during transcription. Cell 128:707-719.
65. Liang G, Klose RJ, Gardner KE, Zhang Y. 2007. Yeast Jhd2p is a histone H3 Lys4 trimethyl demethylase. Nat Struct Mol Biol 14:243-245.
66. Lonard DM, O'Malley BW. 2007. Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Mol Cell 27:691-700.
67. Lonard DM, Nawaz Z, Smith CL, O'Malley BW. 2000. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol Cell 5:939-948.
68. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. 1995. The nuclear receptor superfamily: The second decade. Cell 83:835-839.
69. Martin C, Zhang Y. 2005. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6:838-849.
70. Martin C, Zhang Y. 2007. Mechanisms of epigenetic inheritance. Curr Opin Cell Biol 19:266-272.
71. McNaught KS, Perl DP, Brownell AL, Olanow CW. 2004. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 56:149-162.
72. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F. 2003. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763.
73. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R, Schule R. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437:436-439.
74. Mills IG, Gaughan L, Robson C, Ross T, McCracken S, Kelly J, Neal DE. 2005. Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors. J Cell Biol 170:191-200.
75. Mo R, Rao SM, Zhu YJ. 2006. Identification of the MLL2 complex as a coactivator for estrogen receptor α. J Biol Chem 281:15714-15720.
76. Muller J, Kassis JA. 2006. Polycomb response elements and targeting of Polycomb group proteins in Drosophila. Curr Opin Genet Dev 16:476-484.
77. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
78. Nawaz Z, O'Malley BW. 2004. Urban renewal in the nucleus: Is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18:493-499.
79. Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J, McLachlan JA. 1998. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 19:1655-1663.
80. Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J, McLachlan JA. 2000. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 21:1355-1363.
81. Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin SP, Allis CD, Cheng X, Bestor TH. 2007. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448:714-717.
82. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.
83. Ptashne M. 2007. On the use of the word 'epigenetic'. Curr Biol 17:R233-R236.
84. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707.
85. Ringrose L, Paro R. 2007. Polycomb/Trithorax response elements and epigenetic memory of cell identity. Development 134:223-232.
86. Robertson KD. 2005. DNA methylation and human disease. Nat Rev Genet 6:597-610.
87. Roccaro AM, Hideshima T, Richardson PG, Russo D, Ribatti D, Vacca A, Dammacco F, Anderson KC. 2006. Bortezomib as an antitumor agent. Curr Pharm Biotechnol 7:441-448.
88. Ruden DM, Xiao L, Garfinkel MD, Lu X. 2005. Hsp90 and environmental impacts on epigenetic states: A model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet 14 (Spec No 1):R149-R155.
89. Ruthenburg AJ, Allis CD, Wysocka J. 2007. Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark. Mol Cell 25:15-30.
90. Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ. 2006. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci USA 103:19176-19181.
91. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T. 2004. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6:73-77.
92. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. 2007. Genome regulation by polycomb and trithorax proteins. Cell 128:735-745.
93. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ III. 2002. SETDB1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16:919-932.
94. Schwartz YB, Pirrotta V. 2007. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8:9-22.
95. Scoumanne A, Chen X. 2007. The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J Biol Chem 282:15471-15475.
96. Secombe J, Li L, Carlos L, Eisenman RN. 2007. The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 21:537-551.
97. Shi Y, Whetstine JR. 2007. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 25:1-14.
98. Shin S, Janknecht R. 2007. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun 359:742-746.
99. Sikder D, Johnston SA, Kodadek T. 2006. Widespread, but non-identical, association of proteasomal 19 and 20 S proteins with yeast chromatin. J Biol Chem 281:27346-27355.
100. Sims RJ III, Reinberg D. 2006. Histone H3 Lys 4 methylation: Caught in a bind? Genes Dev 20:2779-2786.
101. Smallwood A, Esteve PO, Pradhan S, Carey M. 2007. Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 21:1169-1178.
102. Szutorisz H, Georgiou A, Tora L, Dillon N. 2006. The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 127:1375-1388.
103. Szyf M, Weaver I, Meaney M. 2007. Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol 24:9-19.
104. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, Shi Y. 2007. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447:601-605.
105. Terranova R, Agherbi H, Boned A, Meresse S, Djabali M. 2006. Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Ml1. Proc Natl Acad Sci USA 103:6629-6634.
106. Trewick SC, McLaughlin PJ, Allshire RC. 2005. Methylation: Lost in hydroxylation? EMBO Rep 6:315-320.
107. Van Speybroeck L. 2002. From epigenesis to epigenetics: The case of C. H. Waddington. Ann NY Acad Sci 981:61-81.
108. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, de Launoit Y, Furks F. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439:871-874.
109. Voges D, Zwickl P, Baumeister W. 1999. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015-1068.
110. Wade PA. 2001. Methyl CpG binding proteins: Coupling chromatin architecture to gene regulation. Oncogene 20:3166-3173.
111. Wade PA, Archer TK. 2006. Epigenetics: Environmental instructions for the genome. Environ Health Perspect 114:A140-A141.
112. Wallace AD, Cidlowski JA. 2001. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276:42714-42721.
113. Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A, Ohgi KA, Zhu P, Garcia-Bassets I, Liu F, Taylor H, Lozach J, Jayes FL, Korach KS, Glass CK, Fu XD, Rosenfeld MG. 2007. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446:882-887.
114. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. 2004. Epigenetic programming by maternal behavior. Nat Neurosci 7:847-854.
115. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D. 2007. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39:457-466.
116. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M, Shi Y. 2006. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125:467-481.
117. Winkler GS, Mulder KW, Bardwell VJ, Kalkhoven E, Timmers HT. 2006. Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription. EMBO J 25:3089-3099.
118. Wissmann M, Yin N, Muller JM, Greschik H, Fodor BD, Jenuwein T, Vogler C, Schneider R, Gunther T, Buettner R, Metzger E, Schule R. 2007. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 9:347-353.
119. Wolf SS, Patchev VK, Obendorf M. 2007. A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. Arch Biochem Biophys 460:56-66.
120. Wolffe AP. 1998. Packaging principle: How DNA methylation and histone acetylation control the transcriptional activity of chromatin. J Exp Zool 282:239-244.
121. Wu J, Ellison J, Salido E, Yen P, Mohandas T, Shapiro LJ. 1994. Isolation and characterization of XE169, a novel human gene that escapes X-inactivation. Hum Mol Genet 3:153-160.
122. Wu J, Wang SH, Potter D, Liu JC, Smith LT, Wu YZ, Huang TH, Plass C. 2007. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. BMC Genomics 8:131.
123. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, Wu C, Allis CD. 2006. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442:86-90.
124. Yamamoto KR. 1985. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19:209-252.
125. Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, Taylor-Papadimitriou J, Tempst P, Zhang Y. 2007. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 25:801-812.
126. Zhang D, Yoon HG, Wong J. 2005. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol Cell Biol 25:6404-6414.
127. Zhang H, Sun L, Liang J, Yu W, Zhang Y, Wang Y, Chen Y, Li R, Sun X, Shang Y. 2006. The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J 25:4223-4233.